ligand-receptor binding studies demonstrated that streptococcal chemotactic factor inactivator ( scfi ) -treated c5a expressed a greatly reduced ability to bind to receptors of polymorphonuclear leukocytes as compared with native c5a .
C1517880
ligand
C0597357
studies